S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Italy's Lake Garda shrinks to near-historic low amid drought
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Germans urged to cap heat in offices this winter to save gas
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Italy's Lake Garda shrinks to near-historic low amid drought
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Germans urged to cap heat in offices this winter to save gas
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Italy's Lake Garda shrinks to near-historic low amid drought
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Germans urged to cap heat in offices this winter to save gas
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Italy's Lake Garda shrinks to near-historic low amid drought
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Germans urged to cap heat in offices this winter to save gas
The 7 Types Of People Every Entrepreneur Needs In Their Inner Circle -- And How To Find Them
Former Deutsche Bank Co-CEO Anshu Jain dies
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
NASDAQ:DOCS

Doximity - DOCS Stock Forecast, Price & News

$37.98
-0.71 (-1.84%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$37.86
$38.77
50-Day Range
$32.37
$46.17
52-Week Range
$27.06
$107.79
Volume
1.44 million shs
Average Volume
2.34 million shs
Market Capitalization
$7.33 billion
P/E Ratio
54.26
Dividend Yield
N/A
Price Target
$46.57

Doximity MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.62 Rating Score
Upside/​Downside
22.6% Upside
$46.57 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.19mentions of Doximity in the last 14 days
Based on 8 Articles This Week
Insider Trading
Acquiring Shares
$482,850 Bought Last Quarter
Proj. Earnings Growth
25.45%
From $0.55 to $0.69 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.91 out of 5 stars

Medical Sector

42nd out of 1,135 stocks

Custom Computer Programming Services Industry

4th out of 30 stocks

About Doximity

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on DOCS. Piper Sandler decreased their price target on shares of Doximity from $44.00 to $39.00 in a research note on Friday, August 5th. Bank of America downgraded shares of Doximity from a "neutral" rating to an "underperform" rating and reduced their target price for the company from $43.00 to $29.00 in a research note on Friday, August 5th. Jefferies Financial Group reduced their target price on shares of Doximity from $78.00 to $46.00 and set a "buy" rating on the stock in a research note on Wednesday, May 18th. Canaccord Genuity Group reduced their target price on shares of Doximity from $47.00 to $42.00 and set a "buy" rating on the stock in a research note on Friday, August 5th. Finally, Raymond James reduced their target price on shares of Doximity from $60.00 to $40.00 in a research note on Wednesday, May 18th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and eleven have given a buy rating to the company's stock. Based on data from MarketBeat.com, Doximity has an average rating of "Moderate Buy" and an average target price of $48.47.

Doximity Price Performance

Shares of Doximity stock opened at $37.98 on Friday. Doximity has a 1 year low of $27.06 and a 1 year high of $107.79. The firm's 50-day moving average is $39.03 and its two-hundred day moving average is $43.85. The stock has a market cap of $7.33 billion, a price-to-earnings ratio of 54.26, a PEG ratio of 19.13 and a beta of 0.78.

Doximity (NASDAQ:DOCS - Get Rating) last issued its earnings results on Tuesday, May 17th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.08. Doximity had a net margin of 41.72% and a return on equity of 17.99%. The company had revenue of $93.65 million for the quarter, compared to analysts' expectations of $90.17 million. Doximity's revenue was up 40.4% on a year-over-year basis. On average, equities analysts expect that Doximity will post 0.55 earnings per share for the current year.

Insiders Place Their Bets

In other news, CRO Paul W. Jorgensen purchased 15,000 shares of the stock in a transaction dated Friday, May 20th. The shares were acquired at an average cost of $32.19 per share, for a total transaction of $482,850.00. Following the acquisition, the executive now owns 197,676 shares of the company's stock, valued at $6,363,190.44. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. 45.21% of the stock is owned by company insiders.

Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter.

DOCS Stock News Headlines

Doximity (NASDAQ:DOCS) Shares Down 10.7% After Analyst Downgrade
Doximity (NASDAQ:DOCS) Price Target Cut to $42.00
For DOCS, the Writing Is on the Wall
Doximity: Q1 Earnings Insights - Benzinga
Doximity (DOCS) to Release Earnings on Thursday
Doximity (NASDAQ:DOCS) Trading Down 7.8%
See More Headlines
Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter.

DOCS Company Calendar

Last Earnings
5/17/2022
Today
8/14/2022
Next Earnings (Estimated)
11/08/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Custom computer programming services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DOCS
Fax
N/A
Employees
850
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$46.57
High Stock Price Forecast
$72.00
Low Stock Price Forecast
$29.00
Forecasted Upside/Downside
+22.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.62
Research Coverage
13 Analysts

Profitability

Net Income
$154.78 million
Pretax Margin
30.86%

Debt

Sales & Book Value

Annual Sales
$343.55 million
Cash Flow
$0.77 per share
Book Value
$4.67 per share

Miscellaneous

Free Float
105,804,000
Market Cap
$7.33 billion
Optionable
Not Optionable
Beta
0.78














DOCS Stock - Frequently Asked Questions

Should I buy or sell Doximity stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last twelve months. There are currently 2 sell ratings, 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" DOCS shares.
View DOCS analyst ratings
or view top-rated stocks.

What is Doximity's stock price forecast for 2022?

13 Wall Street research analysts have issued 12-month price targets for Doximity's stock. Their DOCS share price forecasts range from $29.00 to $72.00. On average, they expect the company's share price to reach $46.57 in the next twelve months. This suggests a possible upside of 22.6% from the stock's current price.
View analysts price targets for DOCS
or view top-rated stocks among Wall Street analysts.

How have DOCS shares performed in 2022?

Doximity's stock was trading at $50.13 on January 1st, 2022. Since then, DOCS shares have decreased by 24.2% and is now trading at $37.98.
View the best growth stocks for 2022 here
.

When is Doximity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our DOCS earnings forecast
.

How were Doximity's earnings last quarter?

Doximity, Inc. (NASDAQ:DOCS) issued its quarterly earnings data on Tuesday, May, 17th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.09 by $0.08. The business earned $93.65 million during the quarter, compared to the consensus estimate of $90.17 million. Doximity had a trailing twelve-month return on equity of 17.99% and a net margin of 41.72%. The company's revenue was up 40.4% on a year-over-year basis.

What guidance has Doximity issued on next quarter's earnings?

Doximity issued an update on its FY 2023 earnings guidance on Thursday, August, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $424.00 million-$432.00 million, compared to the consensus revenue estimate of $455.23 million.

When did Doximity IPO?

(DOCS) raised $501 million in an initial public offering (IPO) on Thursday, June 24th 2021. The company issued 23,300,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

What is Doximity's stock symbol?

Doximity trades on the NASDAQ under the ticker symbol "DOCS."

Who are Doximity's major shareholders?

Doximity's stock is owned by a number of institutional and retail investors. Top institutional investors include FMR LLC (4.01%), Clearbridge Investments LLC (2.32%), Allianz Asset Management GmbH (2.10%), Loomis Sayles & Co. L P (1.41%), Credit Suisse AG (0.99%) and Baird Financial Group Inc. (0.83%). Insiders that own company stock include Anna Bryson, Gilbert H Kliman, Interwest Partners X Lp, Joseph B Kleine, Kevin Spain, Kira Scherer Wampler and Paul W Jorgensen.
View institutional ownership trends
.

How do I buy shares of Doximity?

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Doximity's stock price today?

One share of DOCS stock can currently be purchased for approximately $37.98.

How much money does Doximity make?

Doximity (NASDAQ:DOCS) has a market capitalization of $7.33 billion and generates $343.55 million in revenue each year. The company earns $154.78 million in net income (profit) each year or $0.70 on an earnings per share basis.

How many employees does Doximity have?

The company employs 850 workers across the globe.

How can I contact Doximity?

The official website for the company is www.doximity.com. The company can be reached via phone at 650-549-4330 or via email at ir@doximity.com.

This page (NASDAQ:DOCS) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.